Precision Theranostics Inc

The team has extensive expertise in respiratory medicine, biotechnology, and drug and medical device development. PTNx translates laboratory discoveries into clinical applications (bench to bedside) to improve survival and prevent progression of chronic or fatal conditions.

Mission

Precision Theranostics is focused on development of novel diagnostics, therapeutics and prognosis-based therapies for:

• Chronic respiratory diseases
• Age-related disorders

The core belief is that innovative, prognosis-based early intervention is key to improving survival and finding cures for chronic or fatal diseases.

Areas of Scientific Expertise

• Prognosis-based intervention strategies for respiratory diseases
• Age-related and smoke-induced accelerated lung aging
• Development of theranostic (diagnostic + therapeutic) solutions
• Bench-to-bedside clinical translation based on peer-reviewed proof-of-concept research

Leadership (Summary)

• Principal and Founder: Dr. Neeraj Vij, President and CEO of Precision Theranostics and VIJ BIOTECH
• Background: PhD in Biotechnology; extensive postdoctoral and faculty experience at leading universities and medical schools
• Focus: Development of prognosis-based intervention strategies and training of students and fellows in translational research

For detailed biographies and advisory board information, please refer callers to the company website or to the leadership directly.

The company focuses on early diagnosis and intervention for:

• Chronic Obstructive Pulmonary Disease (COPD)
• Emphysema
• Idiopathic Pulmonary Fibrosis (IPF)
• Cystic Fibrosis
• Other chronic lung conditions triggered or worsened by:
• Biomass smoke
• Cigarette smoke
• E-cigarette vapors
• Air pollution

Approach

• Early diagnosis is emphasized as the key to improving survival and finding cures for a variety of lung conditions.
• Development of LungHealth Diagnostics to enable prognosis-based early intervention in susceptible individuals.
• Focus on understanding susceptibility factors and disease triggers to support targeted screening and intervention.

Goals

• Enable timely identification of individuals at risk for chronic or progressive lung disease.
• Support development of integrated diagnostic and therapeutic (theranostic) strategies.
• Improve long-term outcomes by intervening before advanced disease develops.

Phone Contacts

• General/Business phone: 443-900-0104
• Leadership / Scientific contact:
• Email: nvij@precisiontheranostic.com (Dr. Neeraj Vij)
• Phone: 240-623-0757

How to Get in Touch

• For general inquiries, partnership discussions, or information about theranostic programs, use info@precisiontheranostic.com or the general business phone number.
• For scientific collaboration or leadership inquiries, contact Dr. Neeraj Vij at nvij@precisiontheranostic.com or 240-623-0757.

If callers need more detailed or updated contact options (such as web contact forms), direct them to the Contact Us page on the company website.

Lists Baltimore, Mission, Appleton, Elko, and Opportunity as a location. Areas beyond these are not published.

Programs focus on conditions such as:

• Age-related neurodegenerative disorders
• Age-related macular degeneration (AMD)
• Smoke-induced accelerated lung aging

These conditions involve changes in cellular homeostatic processes that can serve as early prognostic indicators of disease initiation.

Approach

• Identify and characterize early cellular and molecular changes associated with aging and age-related diseases.
• Develop prognosis-based intervention strategies that aim to:
• Detect disease at a very early stage
• Enable timely therapeutic intervention
• Slow or prevent progression where possible

Objectives

• Provide novel intervention strategies for age-related disorders using theranostic approaches.
• Integrate diagnostics and targeted therapies to personalize care for susceptible or affected individuals.

• Candidates interested in opportunities at Precision Theranostics are invited to send a resume by email.

How to Apply

• Application email: info@precisiontheranostic.com
• In your message, include:
• Your resume or CV
• A brief cover note outlining your background and areas of interest

Employment Policy

• Precision Theranostics states that it is an Equal Opportunity Employer.
• The company indicates that it offers a competitive salary and benefits package; specific roles, salaries or benefits are not listed publicly.

For the most up-to-date information on open positions, applicants should reach out directly via info@precisiontheranostic.com.

• Focus on acquired dysfunctions and inherent genetic factors that contribute to chronic and fatal diseases.
• Aim to:
• Identify individuals who are especially susceptible to disease triggers (such as environmental or biomass smoke and aging)
• Provide targeted intervention for these high-risk groups

Personalized Intervention Strategy

• Use prognosis-based screening and diagnostics to identify at-risk or early-stage patients.
• Design interventions that are tailored to the individual's underlying susceptibility and disease mechanisms.
• Goals include:
• Increasing treatment efficacy
• Reducing adverse side effects
• Enabling earlier intervention than is possible with conventional approaches

Example Application

For restrictive or chronic lung conditions where susceptibility factors trigger or worsen disease (e.g. through smoke exposure or aging), early screening combined with targeted intervention is intended to help improve survival and long-term outcomes.

Ask anyway — the agent will say plainly that it is not published rather than guess.